CD34 and endothelial dysfunction: Although there have been many different markers of inflammation used to look at endothelial dysfunction, cell-based biomarker such as hematopoietic progenitor cells CD34+ cells to assess endothelial function and treat cardiovascular diseases [8–12] has been widely used in various clinical scenarios [10].